Chief Business Officer · 10x Genomics, Inc. (TXG)

Ruth De Backer

A named executive officer of 10x Genomics in every fiscal year CompBrief holds from FY2018 to FY2020. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$10,971,399

Salary $237,808Stock awards $4,345,338

FY2019: $1,473,020

1st of 6 named executive officers at 10x Genomics by FY2020 total.

6 named officers on file for 10x Genomics, FY2020

Ruth De Backer’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 1 equity grant, each cited to its filing
  • TXG’s disclosed peer group of 19 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how 10x Genomics’s whole pay program stands against its peers

  • 10x Genomics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on TXG→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 23, 2021 (DEF 14A).

Free

Get Ruth De Backer’s full pay file as a PDF — free

More than this page: up to 10 years of Ruth’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Ruth De Backer compensation by year

10x Genomics Summary Compensation Table · all 3 fiscal years held
In US dollars, as 10x Genomics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2018FY2019FY2020
Salary$316,340$334,902$237,808
Bonus$21,748$24,071$0
Stock awards$0$0$4,345,338
Option awards$480,845$1,056,276$6,288,253
Non-equity incentive$55,850$57,771$0
Pension and deferred compensation$0$0$0
All other$0$0$100,000
Total$874,783$1,473,020$10,971,399

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: 10x Genomics, Inc. DEF 14A filed April 23, 2021, accession 0001770787-21-000024, and prior-year filings. Open the filing on EDGAR.

How this page was built: the 10x Genomics, Inc. filed document, accession 0001770787-21-000024. Every figure is read from that document and cited to the page and table it appears in. Filed April 23, 2021.

$875K
$1.5M
$11.0M
FY18
FY19
FY20
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2020 year-end
TypeUnvested unitsValue at year-endExercise price
Option4,100—$97.51
Option107,307—$97.51
Option44,563—$0.00

Per the Outstanding Equity Awards at Fiscal Year-End table in 10x Genomics, Inc.'s FY2020 proxy; value at the fiscal year-end close, as the company printed it.

10x Genomics’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Ruth De Backer · this pageChief Business Officer$10,971,399
Serge SaxonovChief Executive Officer$10,882,717
Benjamin HindsonPresident and Chief Scientific Officer$6,515,511
Eric WhitakerChief Legal Officer$5,847,185
Bradford CrutchfieldChief Commercial Officer$4,283,649
Justin McAnearChief Financial Officer$4,263,816

The full 10x Genomics compensation record

free company brief

This page is one person within 10x Genomics's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the 10x Genomics proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are 10x Genomics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Ruth De Backer's compensation dossier · One-time report. No refunds.